⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PSTV News
PLUS THERAPEUTICS, Inc. Common Stock
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
globenewswire.com
PSTV
ELV
Plus Therapeutics to Provide Business Update Call on June 30, 2026
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
Plus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory
globenewswire.com
PSTV
Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases
globenewswire.com
PSTV
Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
Form 8-K
sec.gov
PSTV
Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout
globenewswire.com
PSTV
Plus Therapeutics Announces Oral Presentation Highlighting REYOBIQ™ Clinical and Translational Data Demonstrating Favorable Safety, Survival, and Emerging Immunomodulation in Leptomeningeal Metastases
globenewswire.com
PSTV